Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cryolife (CRY)

Cryolife (CRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 810,946
  • Shares Outstanding, K 38,857
  • Annual Sales, $ 276,220 K
  • Annual Income, $ 1,720 K
  • 60-Month Beta 1.37
  • Price/Sales 2.82
  • Price/Cash Flow 25.05
  • Price/Book 2.38
Trade CRY with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year 0.10
  • Growth Rate Est. (year over year) -120.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.60 +25.72%
on 10/30/20
21.16 -1.37%
on 11/10/20
+1.53 (+7.91%)
since 10/23/20
3-Month
16.13 +29.39%
on 09/14/20
21.16 -1.37%
on 11/10/20
+0.97 (+4.87%)
since 08/21/20
52-Week
12.63 +65.24%
on 03/23/20
31.77 -34.31%
on 01/29/20
-3.29 (-13.62%)
since 11/22/19

Most Recent Stories

More News
CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020

, /PRNewswire/ -- , a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors and analysts to discuss progress with the Company's...

CRY : 20.87 (+4.14%)
Prosthetic Heart Valve/ Artificial Heart Valve Market Research Report by Application, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

The Prosthetic Heart Valve/ Artificial Heart Valve Market is expected to exceed more than US$ 9 Billion by 2024 at a CAGR of 13% in the given forecast period.

CRY : 20.87 (+4.14%)
EW : 84.70 (+0.20%)
LIVN : 51.03 (+2.72%)
MDT : 110.97 (+0.74%)
NVCN.TO : 1.14 (unch)
Prosthetic Heart Valve Market Research Report by Type, by Sensor, by Technology, by End-use Industry – Global Forecast to 2025 – Cumulative Impact of COVID-19

The Global is expected to exceed more than USD$ 4 Billion by 2024; Growing at a CAGR of more than 9% in the given forecast period.

ABT : 109.27 (-1.46%)
BSX : 33.33 (-1.10%)
CRY : 20.87 (+4.14%)
EW : 84.70 (+0.20%)
LIFE : 3.51 (+5.41%)
NVCN.TO : 1.14 (unch)
STJ : 80.82 (+0.16%)
CryoLife (CRY) Q3 Earnings and Revenues Surpass Estimates

CryoLife (CRY) delivered earnings and revenue surprises of 1400.00% and 12.49%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

CRY : 20.87 (+4.14%)
US Heart Valve Repair and Replacement Market: Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2025

Heart Valve Repair and Replacement Market is valued at USD 6017.58 Million in 2018 and expected to reach USD 12104.80 Million by 2025 with the CAGR of 10.5% over the forecast period.

AORTF : 4.5223 (unch)
BSX : 33.33 (-1.10%)
CRY : 20.87 (+4.14%)
LIFE : 3.51 (+5.41%)
MDT : 110.97 (+0.74%)
NVCN.TO : 1.14 (unch)
STJ : 80.82 (+0.16%)
CryoLife Reports Third Quarter 2020 Financial Results

, /PRNewswire/ --

CRY : 20.87 (+4.14%)
CryoLife, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 4, 2020 / CryoLife, Inc. (NYSE:CRY) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 4, 2020 at 4:30 PM Eastern...

CRY : 20.87 (+4.14%)
Bioadhesive Market Research Report by Type, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

, /PRNewswire/ --Read the full report: The Global Bioadhesive Market is expected to grow from in 2019 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.81%.Market Segmentation & Coverage:This...

ASH : 77.00 (-0.39%)
CRY : 20.87 (+4.14%)
TATYY : 34.5950 (+0.70%)
US Heart Valve Repair and Replacement Market Size | 2020, Growth Strategies, Opportunity, Challenges, Rising Trends and Revenue Analysis 2025

The delivers a succinct analysis on industry size, regional growth and revenue forecasts for the upcoming years. The report further sheds light on significant challenges and latest growth strategies adopted...

AORTF : 4.5223 (unch)
BSX : 33.33 (-1.10%)
CRY : 20.87 (+4.14%)
LIFE : 3.51 (+5.41%)
MDT : 110.97 (+0.74%)
NVCN.TO : 1.14 (unch)
STJ : 80.82 (+0.16%)
Prosthetic Heart Valve/ Artificial Heart Valve Market Research: Growth Opportunities Regions, Types, Applications, Detail Research for Business Development Insights [2020-2025]

The Prosthetic Heart Valve/ Artificial Heart Valve Market is expected to exceed more than US$ 9 Billion by 2024 at a CAGR of 13% in the given forecast period.

CRY : 20.87 (+4.14%)
EW : 84.70 (+0.20%)
LIVN : 51.03 (+2.72%)
MDT : 110.97 (+0.74%)
NVCN.TO : 1.14 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical...

See More

Key Turning Points

2nd Resistance Point 21.51
1st Resistance Point 21.19
Last Price 20.87
1st Support Level 20.24
2nd Support Level 19.60

See More

52-Week High 31.77
Fibonacci 61.8% 24.46
Fibonacci 50% 22.20
Last Price 20.87
Fibonacci 38.2% 19.94
52-Week Low 12.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar